Bitterroot
Initial Transaction Details
Transaction Date
May 2021
Purpose of Financing
Venture
Stage of Company
Seed/Startup
Structure of Financing
Debt and Equity
Bitterroot Bio is committed to pioneering the emerging field of cardio-immunology, which investigates the interplay between the immune system and cardiovascular health. Bitterroot Bio’s research has uncovered the critical roles that immune cells and modulators of inflammation play in the initiation and progression of cardiovascular disease.
Website